US Stock MarketDetailed Quotes

HRMY Harmony Biosciences

Watchlist

31.700
+0.340+1.08%

Close May 8 16:00 ET

31.700
0.0000.00%

Post 16:20 ET

1.80BMarket Cap13.66P/E (TTM)

Harmony Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-26.83%31.14M

51.86%219.39M

187.37%76.67M

14.30%63.1M

9.88%37.06M

47.51%42.56M

46.58%144.47M

-28.92%26.68M

81.45%55.21M

86.67%33.73M

Net income from continuing operations

30.01%38.33M

-28.99%128.85M

-45.15%26.61M

-56.27%38.46M

45.77%34.3M

37.24%29.49M

424.52%181.47M

113.56%48.51M

1,014.17%87.94M

66.69%23.53M

Operating gains losses

----

--9.77M

--0

----

Depreciation and amortization

0.99%6.12M

4.17%24.36M

0.94%6.13M

0.71%6.11M

0.15%6.06M

16.64%6.06M

24.12%23.39M

27.48%6.07M

29.77%6.06M

28.04%6.06M

Deferred tax

-1.02%-3.48M

84.39%-13.42M

126.34%1.12M

91.54%-6.91M

---4.19M

---3.44M

---85.94M

---4.26M

---81.68M

--0

Other non cash items

380.42%687K

48.00%5.8M

126.80%2.99M

157.54%1.67M

12.37%999K

-86.57%143K

46.09%3.92M

520.77%1.32M

-63.19%650K

151.84%889K

Change In working capital

-643.21%-20.33M

953.26%35.04M

199.57%31.64M

-80.90%6.73M

-76.01%-7.08M

206.16%3.74M

-750.71%-4.11M

-614.74%-31.78M

998.25%35.22M

20.14%-4.02M

-Change in receivables

-357.69%-5.58M

2.50%-19.4M

-2,215.69%-6.88M

34.16%-3.45M

3.87%-11.24M

165.81%2.17M

-57.08%-19.9M

119.85%325K

-160.72%-5.24M

-54.21%-11.69M

-Change in inventory

-338.65%-494K

-889.63%-1.07M

30.48%-276K

-175.65%-233K

-296.40%-764K

225.45%207K

122.17%135K

-206.43%-397K

110.96%308K

171.25%389K

-Change in prepaid assets

-680.91%-3.44M

100.98%74K

164.45%1.83M

-299.80%-3.99M

211.07%1.64M

126.49%592K

-356.07%-7.55M

-238.06%-2.84M

67.77%-997K

-351.53%-1.47M

-Change in payables and accrued expense

-198.40%-2.59M

137.33%55.43M

228.05%36.96M

-65.01%14.4M

-83.57%1.44M

13.42%2.63M

48.68%23.36M

-621.01%-28.86M

407.30%41.15M

155.77%8.75M

-Change in other current liabilities

-344.81%-8.23M

99.34%-1K

--2K

-300.00%-2K

--1.85M

-1,117.11%-1.85M

-3.42%-151K

--0

-98.11%1K

--0

Cash from discontinued investing activities

Operating cash flow

-26.83%31.14M

51.86%219.39M

187.37%76.67M

14.30%63.1M

9.88%37.06M

47.51%42.56M

46.58%144.47M

-28.92%26.68M

81.45%55.21M

86.67%33.73M

Investing cash flow

Cash flow from continuing investing activities

-245.59%-6.19M

67.26%-46.44M

23.09%-36.07M

97.49%-813K

65.38%-7.77M

95.53%-1.79M

-41.41%-141.83M

-46.9M

-34,787.10%-32.45M

-11,067.66%-22.45M

Net PPE purchase and sale

---5K

-81.40%-312K

---107K

--0

-400.00%-205K

--0

42.28%-172K

--0

7.53%-86K

79.60%-41K

Net intangibles purchase and sale

----

--0

----

60.00%-40M

--0

Net business purchase and sale

----

---36.97M

----

--0

----

Net investment purchase and sale

-245.31%-6.18M

90.99%-9.16M

102.15%1.01M

97.49%-813K

66.23%-7.57M

---1.79M

---101.66M

---46.9M

---32.36M

---22.41M

Cash from discontinued investing activities

Investing cash flow

-245.59%-6.19M

67.26%-46.44M

23.09%-36.07M

97.49%-813K

65.38%-7.77M

95.53%-1.79M

-41.41%-141.83M

---46.9M

-34,787.10%-32.45M

-11,067.66%-22.45M

Financing cash flow

Cash flow from continuing financing activities

-206.60%-3.63M

-1,642.93%-105.55M

-2,113.66%-53.52M

-2,787.76%-55.1M

-145.20%-339K

146.49%3.41M

-7.79%6.84M

-62.42%2.66M

754.95%2.05M

15.74%750K

Net issuance payments of debt

-650.00%-3.75M

37.50%-1.25M

-39,950.00%-200.25M

40,100.00%200M

0.00%-500K

-300.00%-2M

-102.33%-500K

97.73%-500K

---500K

Net common stock issuance

----

---100M

-12,154.90%-50M

----

--0

---408K

----

Proceeds from stock option exercised by employees

-97.03%116K

-42.82%5.06M

-93.63%227K

-88.61%244K

-46.00%675K

107.59%3.91M

-5.66%8.84M

-52.94%3.57M

88.89%2.14M

92.90%1.25M

Net other financing activities

----

---9.36M

--196.5M

---205.34M

----

Cash from discontinued financing activities

Financing cash flow

-206.60%-3.63M

-1,642.93%-105.55M

-2,113.66%-53.52M

-2,787.76%-55.1M

-145.20%-339K

146.49%3.41M

-7.79%6.84M

-62.42%2.66M

754.95%2.05M

15.74%750K

Net cash flow

Beginning cash position

27.56%311.93M

4.03%244.53M

23.95%324.85M

33.88%317.67M

28.17%288.71M

4.03%244.53M

2.48%235.06M

37.61%262.09M

47.90%237.28M

58.72%225.25M

Current changes in cash

-51.74%21.32M

611.30%67.4M

26.40%-12.92M

-71.03%7.19M

140.59%28.95M

550.34%44.18M

66.87%9.48M

-139.37%-17.56M

-17.35%24.81M

-35.01%12.03M

End cash Position

15.43%333.25M

27.56%311.93M

23.95%324.85M

33.88%317.67M

28.17%288.71M

4.03%244.53M

37.61%262.09M

47.90%237.28M

Free cash flow

-26.84%31.14M

110.06%219.08M

186.97%76.56M

14.48%63.1M

9.40%36.86M

480.23%42.56M

6,090.47%104.29M

-28.92%26.68M

81.72%55.12M

88.54%33.69M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-26.83%31.14M	51.86%219.39M	187.37%76.67M	14.30%63.1M	9.88%37.06M	47.51%42.56M	46.58%144.47M	-28.92%26.68M	81.45%55.21M	86.67%33.73M
Net income from continuing operations	30.01%38.33M	-28.99%128.85M	-45.15%26.61M	-56.27%38.46M	45.77%34.3M	37.24%29.49M	424.52%181.47M	113.56%48.51M	1,014.17%87.94M	66.69%23.53M
Operating gains losses	----	--9.77M	--0	----	----	----	----	----	----	----
Depreciation and amortization	0.99%6.12M	4.17%24.36M	0.94%6.13M	0.71%6.11M	0.15%6.06M	16.64%6.06M	24.12%23.39M	27.48%6.07M	29.77%6.06M	28.04%6.06M
Deferred tax	-1.02%-3.48M	84.39%-13.42M	126.34%1.12M	91.54%-6.91M	---4.19M	---3.44M	---85.94M	---4.26M	---81.68M	--0
Other non cash items	380.42%687K	48.00%5.8M	126.80%2.99M	157.54%1.67M	12.37%999K	-86.57%143K	46.09%3.92M	520.77%1.32M	-63.19%650K	151.84%889K
Change In working capital	-643.21%-20.33M	953.26%35.04M	199.57%31.64M	-80.90%6.73M	-76.01%-7.08M	206.16%3.74M	-750.71%-4.11M	-614.74%-31.78M	998.25%35.22M	20.14%-4.02M
-Change in receivables	-357.69%-5.58M	2.50%-19.4M	-2,215.69%-6.88M	34.16%-3.45M	3.87%-11.24M	165.81%2.17M	-57.08%-19.9M	119.85%325K	-160.72%-5.24M	-54.21%-11.69M
-Change in inventory	-338.65%-494K	-889.63%-1.07M	30.48%-276K	-175.65%-233K	-296.40%-764K	225.45%207K	122.17%135K	-206.43%-397K	110.96%308K	171.25%389K
-Change in prepaid assets	-680.91%-3.44M	100.98%74K	164.45%1.83M	-299.80%-3.99M	211.07%1.64M	126.49%592K	-356.07%-7.55M	-238.06%-2.84M	67.77%-997K	-351.53%-1.47M
-Change in payables and accrued expense	-198.40%-2.59M	137.33%55.43M	228.05%36.96M	-65.01%14.4M	-83.57%1.44M	13.42%2.63M	48.68%23.36M	-621.01%-28.86M	407.30%41.15M	155.77%8.75M
-Change in other current liabilities	-344.81%-8.23M	99.34%-1K	--2K	-300.00%-2K	--1.85M	-1,117.11%-1.85M	-3.42%-151K	--0	-98.11%1K	--0
Cash from discontinued investing activities
Operating cash flow	-26.83%31.14M	51.86%219.39M	187.37%76.67M	14.30%63.1M	9.88%37.06M	47.51%42.56M	46.58%144.47M	-28.92%26.68M	81.45%55.21M	86.67%33.73M
Investing cash flow
Cash flow from continuing investing activities	-245.59%-6.19M	67.26%-46.44M	23.09%-36.07M	97.49%-813K	65.38%-7.77M	95.53%-1.79M	-41.41%-141.83M	-46.9M	-34,787.10%-32.45M	-11,067.66%-22.45M
Net PPE purchase and sale	---5K	-81.40%-312K	---107K	--0	-400.00%-205K	--0	42.28%-172K	--0	7.53%-86K	79.60%-41K
Net intangibles purchase and sale	----	--0	--0	--0	----	----	60.00%-40M	--0	--0	--0
Net business purchase and sale	----	---36.97M	----	----	----	----	--0	----	----	----
Net investment purchase and sale	-245.31%-6.18M	90.99%-9.16M	102.15%1.01M	97.49%-813K	66.23%-7.57M	---1.79M	---101.66M	---46.9M	---32.36M	---22.41M
Cash from discontinued investing activities
Investing cash flow	-245.59%-6.19M	67.26%-46.44M	23.09%-36.07M	97.49%-813K	65.38%-7.77M	95.53%-1.79M	-41.41%-141.83M	---46.9M	-34,787.10%-32.45M	-11,067.66%-22.45M
Financing cash flow
Cash flow from continuing financing activities	-206.60%-3.63M	-1,642.93%-105.55M	-2,113.66%-53.52M	-2,787.76%-55.1M	-145.20%-339K	146.49%3.41M	-7.79%6.84M	-62.42%2.66M	754.95%2.05M	15.74%750K
Net issuance payments of debt	-650.00%-3.75M	37.50%-1.25M	-39,950.00%-200.25M	40,100.00%200M	0.00%-500K	0.00%-500K	-300.00%-2M	-102.33%-500K	97.73%-500K	---500K
Net common stock issuance	----	---100M	-12,154.90%-50M	----	----	----	--0	---408K	----	----
Proceeds from stock option exercised by employees	-97.03%116K	-42.82%5.06M	-93.63%227K	-88.61%244K	-46.00%675K	107.59%3.91M	-5.66%8.84M	-52.94%3.57M	88.89%2.14M	92.90%1.25M
Net other financing activities	----	---9.36M	--196.5M	---205.34M	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-206.60%-3.63M	-1,642.93%-105.55M	-2,113.66%-53.52M	-2,787.76%-55.1M	-145.20%-339K	146.49%3.41M	-7.79%6.84M	-62.42%2.66M	754.95%2.05M	15.74%750K
Net cash flow
Beginning cash position	27.56%311.93M	4.03%244.53M	23.95%324.85M	33.88%317.67M	28.17%288.71M	4.03%244.53M	2.48%235.06M	37.61%262.09M	47.90%237.28M	58.72%225.25M
Current changes in cash	-51.74%21.32M	611.30%67.4M	26.40%-12.92M	-71.03%7.19M	140.59%28.95M	550.34%44.18M	66.87%9.48M	-139.37%-17.56M	-17.35%24.81M	-35.01%12.03M
End cash Position	15.43%333.25M	27.56%311.93M	27.56%311.93M	23.95%324.85M	33.88%317.67M	28.17%288.71M	4.03%244.53M	4.03%244.53M	37.61%262.09M	47.90%237.28M
Free cash flow	-26.84%31.14M	110.06%219.08M	186.97%76.56M	14.48%63.1M	9.40%36.86M	480.23%42.56M	6,090.47%104.29M	-28.92%26.68M	81.72%55.12M	88.54%33.69M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall